Danish pharmaceutical company — manufacturer of Ozempic, Wegovy, and Victoza — the company that created the GLP-1 agonist drug class that became the most significant pharmaceutical development of the 2020s.
Creates the GLP-1 weight loss drug category — Novo Nordisk's development of semaglutide (Ozempic/Wegovy) produced the most effective obesity treatment in pharmaceutical history and the fastest-growing drug category in the 2020s.
Discussing
Ask anything about Novo Nordisk — their ideas, influences, contradictions, legacy.
Sign in to start a conversation.